Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × vatalanib × Clear all

NCT00293371 2012-10-11

Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer

Phase 1/2 Terminated

Prostatic Neoplasms